Negligence Claim Survives in Calif. Gilead HIV Drug Litigation
January 10, 2024
DOCUMENTS
- Opinion
SAN FRANCISCO — A California appellate court has upheld a ruling denying Gilead Life Sciences Inc. summary judgment on a negligence claim in a coordinated proceeding in which plaintiffs allege the company’s HIV/AIDS drug tenofovir disoproxil fumarate (TDF) caused them to develop skeletal and kidney damage.
In the Jan. 9 opinion, the court explained that “the legal duty of a manufacturer to exercise reasonable care can, in appropriate circumstances, extend beyond the duty not to market a defective product.”
“A variety of cases demonstrate that a manufacturer’s duty of reasonable care can extend more broadly than the duty to …
UPCOMING CONFERENCES
![](https://harrismartin.s3.amazonaws.com/media/CACHE/images/uploads/conferences/iStock-115753557_fLooJhx/ebadaa70c9ae4eba2f27c08bcd68c09c.jpg)
HarrisMartin's Midwest Asbestos Litigation Conference
September 27, 2024 - St. Louis, MO
Four Seasons Hotel, St. Louis